Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6890
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients ; volume:15 ; number:1 ; day:20 ; month:5 ; year:2015 ; pages:1-9 ; date:12.2015
BMC clinical pathology ; 15, Heft 1 (20.5.2015), 1-9, 12.2015
- Urheber
-
Gustbée, Emma
- Beteiligte Personen und Organisationen
-
Tryggvadottir, Helga
Markkula, Andrea
Simonsson, Maria
Nodin, Björn
Jirström, Karin
Rose, Carsten
Ingvar, Christian
Borgquist, Signe
Jernström, Helena
SpringerLink (Online service)
- DOI
-
10.1186/s12907-015-0008-2
- URN
-
urn:nbn:de:1111-2016110317011
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gustbée, Emma
- Tryggvadottir, Helga
- Markkula, Andrea
- Simonsson, Maria
- Nodin, Björn
- Jirström, Karin
- Rose, Carsten
- Ingvar, Christian
- Borgquist, Signe
- Jernström, Helena
- SpringerLink (Online service)
Ähnliche Objekte (12)
Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen
HMG-CoA reductase inhibitors
Transcription of the three HMG-CoA reductase genes of Mucor circinelloides
Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo
Selection of HMG-coenzyme A reductase inhibitors using multiattribute scoring tool
Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol
Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer
Regulated degradation of HMG CoA reductase requires conformational changes in sterol-sensing domain
A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis
Single dose testosterone increases total cholesterol levels and induces the expression of HMG CoA Reductase
Drug Target Mendelian Randomization Study of PCSK9 and HMG-CoA Reductase Inhibition and Atrial Fibrillation
Potential natural inhibitors of xanthine oxidase and HMG-CoA reductase in cholesterol regulation: in silico analysis
Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen
HMG-CoA reductase inhibitors
Transcription of the three HMG-CoA reductase genes of Mucor circinelloides
Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo
Selection of HMG-coenzyme A reductase inhibitors using multiattribute scoring tool
Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol
Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer
Regulated degradation of HMG CoA reductase requires conformational changes in sterol-sensing domain
A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis
Single dose testosterone increases total cholesterol levels and induces the expression of HMG CoA Reductase
Drug Target Mendelian Randomization Study of PCSK9 and HMG-CoA Reductase Inhibition and Atrial Fibrillation
Potential natural inhibitors of xanthine oxidase and HMG-CoA reductase in cholesterol regulation: in silico analysis
Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen
HMG-CoA reductase inhibitors
Transcription of the three HMG-CoA reductase genes of Mucor circinelloides
Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo
Selection of HMG-coenzyme A reductase inhibitors using multiattribute scoring tool
Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol
Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer
Regulated degradation of HMG CoA reductase requires conformational changes in sterol-sensing domain
A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis
Single dose testosterone increases total cholesterol levels and induces the expression of HMG CoA Reductase
Drug Target Mendelian Randomization Study of PCSK9 and HMG-CoA Reductase Inhibition and Atrial Fibrillation